期刊文献+

糖尿病和糖代谢异常/糖耐量异常与非酒精性脂肪肝的相关研究 被引量:6

Diabetes mellitus and impaired fasting glucose /impaired glucose tolerance related to nonalcoholic fatty liver disease
下载PDF
导出
摘要 目的探讨非酒精性脂肪肝(NAFLD)与2型糖尿病、糖代谢异常/糖耐量异常和空腹血糖水平的关系。方法对2 412名健康体检者通过B超检查的方法,观察NAFLD的发病情况,并同时测量身高、体质量、血压,计算体质量指数(BMI),抽血测定空腹血糖、总胆固醇、甘油三酯以及高血压、冠心病的发病情况。比较这些因素在2型糖尿病、糖代谢异常/糖耐量异常和对照组之间的差异,以及NAFLD与空腹血糖的相关性。结果 (1)NAFLD、高血压病、BMI、收缩压、空腹血糖和甘油三酯在2型糖尿病、糖代谢异常/糖耐量异常和对照组之间差异有统计学意义(P<0.05)。(2)Logistic回归分析显示NAFLD与空腹血糖、BMI、舒张压和甘油三酯呈正相关(P<0.05),而与年龄呈负相关(P<0.01)。结论 NAFLD在糖代谢异常/糖耐量异常和2型糖尿病组中升高,NAFLD与空腹血糖、BMI、舒张压和甘油三酯呈正相关。血糖和NAFLD具有相互促进的作用,因此,治疗NAFLD的同时应关注患者血糖的控制。 Objective To explore the relationship of nonalcoholic fatty liver disease (NAFLD) with the differen groups of diabetes, impaired fasting glucose/impaired glucose tolerance and the fasting blood glucose. Methods The prevalence of NAFLD of 2 412 health checkups were observed in the Navy General Hospital of PLA, and the height weight, blood pressure were measured; body mass index (BMI) was eaculated; fasting blood glucose, total cholesterol triglycerides were examined, incidence of hypertension, coronary heart disease were counted. All of the data were com pared in diabetes, impaired fasting glucose/impaired glucose tolerance and normal glucose tolerance, and the relation ship between NAFLD and the fasting blood glucose was analyzed. Results There were significantly differences amon diabetes, impaired fasting glucose/impaired glucose tolerance and normal glucose tolerance in prevalence rate NAFLD, hypertension and levels of BMI, systolic blood pressure, fasting blood glucose and plasma triglyceride (P 0.05 ). The incidence of NAFLD was positively correlated with fasting blood glucose, BMI, diastolic blood pressure ar plasma triglyeeride (P 〈0.05) by Logistic regression analysis, and negatively correlated with age(P 〈0.01 ). Conclu sion The incidence of NAFLD was increased in diabetes, impaired fasting glucose/impaired glucose tolerance and re lated to fasting blood glucose, BMI, diastolic blood pressure and plasma triglyceride. The fasting glucose and NAFLD have mutual promotion effects, so for the treatment of NAFLD patients should pay attention to blood glucose control a the same time.
出处 《胃肠病学和肝病学杂志》 CAS 2014年第4期438-440,共3页 Chinese Journal of Gastroenterology and Hepatology
关键词 非酒精性脂肪肝 空腹血糖 糖尿病 Nonalcoholic fatty liver disease Fasting glucose Diabetes
  • 相关文献

参考文献1

二级参考文献92

  • 1[37]Gholam PM,Flancbaum L,Machan JT,Charney DA,Kotler DP.Nonalcoholic fatty liver disease in severely obese subjects.Am J Gastroenterol 2007; 102:399-408
  • 2[38]Hui JM,Kench JG,Chitturi S,Sud A,Farrell GC,Byth K,Hall P,Khan M,George J.Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.Hepatology 2003; 38:420-427
  • 3[39]Angelico F,Del Ben M,Conti R,Francioso S,Feole K,Fiorello S,Cavallo MG,Zalunardo B,Lirussi F,Alessandri C,Violi F.Insulin resistance,the metabolic syndrome,and nonalcoholic fatty liver disease.J Clin Endocrinol Metab 2005; 90:1578-1582
  • 4[40]Liangpunsakul S,Chalasani N.Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome:results from the third National Health and Nutrition Survey (NHANES Ⅲ).Am J Med Sci 2005; 329:111-116
  • 5[41]Nilssen O,Forde OH,Brenn T.The Tromso Study.Distribution and population determinants of gamma-glutamyltransferase.Am J Epidemiol 1990; 132:318-326
  • 6[42]Robinson D,Whitehead TP.Effect of body mass and other factors on serum liver enzyme levels in men attending for well population screening.Ann Clin Biochem 1989; 26:393-400
  • 7[43]Wannamethee G,Ebrahim S,Shaper AG.Gamma-glutamyltransferase:determinants and association with mortality from ischemic heart disease and all causes.Am J Epidemiol 1995; 142:699-708
  • 8[44]Perry IJ,Wannamethee SG,Shaper AG.Prospective study of serum gamma-glutamyltransferase and risk of NIDDM.Diabetes Care 1998; 21:732-737
  • 9[45]Yamada J,Tomiyama H,Yambe M,Koji Y,Motobe K,Shüna K,Yamamoto Y,Yamashina A.Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome.Atherosclerosis 2006; 189:198-205
  • 10[46]Stranges S,Trevisan M,Dorn JM,Dmochowski J,Donahue RP.Body fat distribution,liver enzymes,and risk of hypertension:evidence from the Western New York Study.Hypertension 2005; 46:1186-1193

共引文献59

同被引文献69

引证文献6

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部